Wednesday, June 7, 2023
BestWooCommerceThemeBuilttoBoostSales-728x90

Young-onset colorectal cancer – Nature Reviews Disease Primers


  • Siegel, R. L., Miller, K. D. & Jemal, A. Cancer statistics, 2018. CA Cancer J. Clin. 68, 7–30 (2018).

    Article 
    PubMed 

    Google Scholar
     

  • Arnold, M. et al. Global patterns and trends in colorectal cancer incidence and mortality. Gut 66, 683–691 (2017).

    Article 
    PubMed 

    Google Scholar
     

  • Malvezzi, M. et al. European cancer mortality predictions for the year 2018 with focus on colorectal cancer. Ann. Oncol. 29, 1016–1022 (2018).

    Article 
    CAS 
    PubMed 

    Google Scholar
     

  • Doubeni, C. A. et al. Effectiveness of screening colonoscopy in reducing the risk of death from right and left colon cancer: a large community-based study. Gut 67, 291–298 (2018).

    Article 
    PubMed 

    Google Scholar
     

  • Stoffel, E. M. & Murphy, C. C. Epidemiology and mechanisms of the increasing incidence of colon and rectal cancers in young adults. Gastroenterology 158, 341–353 (2020).

    Article 
    PubMed 

    Google Scholar
     

  • Akimoto, N. et al. Rising incidence of early-onset colorectal cancer – a call to action. Nat. Rev. Clin. Oncol. 18, 230–243 (2021).

    Article 
    PubMed 

    Google Scholar
     

  • Vuik, F. E. et al. Increasing incidence of colorectal cancer in young adults in Europe over the last 25 years. Gut 68, 1820–1826 (2019).

    Article 
    PubMed 

    Google Scholar
     

  • Siegel, R. L. et al. Global patterns and trends in colorectal cancer incidence in young adults. Gut 68, 2179–2185 (2019).

    Article 
    PubMed 

    Google Scholar
     

  • Lui, R. N. et al. Global increasing incidence of young-onset colorectal cancer across 5 continents: a joinpoint regression analysis of 1,922,167 cases. Cancer Epidemiol. Biomark. Prev. 28, 1275–1282 (2019).

    Article 

    Google Scholar
     

  • Vuik, F. E. R., Nieuwenburg, S. A. V., Nagtegaal, I. D., Kuipers, E. J. & Spaander, M. C. W. Clinicopathological characteristics of early onset colorectal cancer. Aliment. Pharmacol. Ther. 54, 1463–1471 (2021).

    Article 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Brenner, D. R. et al. Increasing colorectal cancer incidence trends among younger adults in Canada. Prev. Med. 105, 345–349 (2017).

    Article 
    PubMed 

    Google Scholar
     

  • Chung, R. Y. et al. A population-based age-period-cohort study of colorectal cancer incidence comparing Asia against the West. Cancer Epidemiol. 59, 29–36 (2019).

    Article 
    PubMed 

    Google Scholar
     

  • O’Connell, J. B. et al. Rates of colon and rectal cancers are increasing in young adults. Am. Surg. 69, 866–872 (2003).

    Article 
    PubMed 

    Google Scholar
     

  • Siegel, R. L., Jemal, A. & Ward, E. M. Increase in incidence of colorectal cancer among young men and women in the United States. Cancer Epidemiol. Biomark. Prev. 18, 1695–1698 (2009).

    Article 

    Google Scholar
     

  • Siegel, R. L. et al. Colorectal cancer incidence patterns in the United States, 1974–2013. J. Natl Cancer Inst. https://doi.org/10.1093/jnci/djw322 (2017).

    Article 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Potter, J. D. Rising rates of colorectal cancer in younger adults. BMJ 365, l4280 (2019).

    Article 
    PubMed 

    Google Scholar
     

  • REACCT Collaborative Characteristics of early-onset vs late-onset colorectal cancer: a review. JAMA Surg. 156, 865–874 (2021).

    Article 

    Google Scholar
     

  • Bailey, C. E. et al. Increasing disparities in the age-related incidences of colon and rectal cancers in the United States, 1975-2010. JAMA Surg. 150, 17–22 (2015).

    Article 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Siegel, R. L. et al. Colorectal cancer statistics, 2020. CA Cancer J. Clin. 70, 145–164 (2020).

    Article 
    PubMed 

    Google Scholar
     

  • Araghi, M. et al. Global trends in colorectal cancer mortality: projections to the year 2035. Int. J. Cancer 144, 2992–3000 (2019).

    Article 
    CAS 
    PubMed 

    Google Scholar
     

  • Venugopal, A. & Carethers, J. M. Epidemiology and biology of early onset colorectal cancer. EXCLI J. 21, 162–182 (2022).

    PubMed 
    PubMed Central 

    Google Scholar
     

  • Muller, C., Ihionkhan, E., Stoffel, E. M. & Kupfer, S. S. Disparities in early-onset colorectal cancer. Cells https://doi.org/10.3390/cells10051018 (2021).

    Article 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • McClelland, P. H., Liu, T. & Ozuner, G. Early-onset colorectal cancer in patients under 50 years of age: demographics, disease characteristics, and survival. Clin. Colorectal Cancer 21, e135–e144 (2022).

    Article 
    PubMed 

    Google Scholar
     

  • Gausman, V. et al. Risk factors associated with early-onset colorectal cancer. Clin. Gastroenterol. Hepatol. 18, 2752–2759.e2 (2020).

    Article 
    PubMed 

    Google Scholar
     

  • Murphy, C. C., Wallace, K., Sandler, R. S. & Baron, J. A. Racial disparities in incidence of young-onset colorectal cancer and patient survival. Gastroenterology 156, 958–965 (2019).

    Article 
    PubMed 

    Google Scholar
     

  • Holowatyj, A. N., Ruterbusch, J. J., Rozek, L. S., Cote, M. L. & Stoffel, E. M. Racial/ethnic disparities in survival among patients with young-onset colorectal cancer. J. Clin. Oncol. 34, 2148–2156 (2016).

    Article 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Sung, J. J. Y. et al. Increasing trend in young-onset colorectal cancer in Asia: more cancers in men and more rectal cancers. Am. J. Gastroenterol. 114, 322–329 (2019).

    Article 
    PubMed 

    Google Scholar
     

  • Holmes, A. J. & Anderson, K. Convergence in national alcohol consumption patterns: new global indicators. J. Wine Econ. 12, 117–148 (2017).

    Article 

    Google Scholar
     

  • Nishida, C., Uauy, R., Kumanyika, S. & Shetty, P. The Joint WHO/FAO Expert Consultation on diet, nutrition and the prevention of chronic diseases: process, product and policy implications. Public Health Nutr. 7, 245–250 (2007).

    Article 

    Google Scholar
     

  • Romaguera, D. et al. Consumption of ultra-processed foods and drinks and colorectal, breast, and prostate cancer. Clin. Nutr. 40, 1537–1545 (2021).

    Article 
    CAS 
    PubMed 

    Google Scholar
     

  • Carroll, K. L., Fruge, A. D., Heslin, M. J., Lipke, E. A. & Greene, M. W. Diet as a risk factor for early-onset colorectal adenoma and carcinoma: a systematic review. Front. Nutr. 9, 896330 (2022).

    Article 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Kwon, J. W. et al. Effects of age, time period, and birth cohort on the prevalence of diabetes and obesity in Korean men. Diabetes Care 31, 255–260 (2008).

    Article 
    PubMed 

    Google Scholar
     

  • Li, H., Boakye, D., Chen, X., Hoffmeister, M. & Brenner, H. Association of body mass index with risk of early-onset colorectal cancer: systematic review and meta-analysis. Am. J. Gastroenterol. 116, 2173–2183 (2021).

    Article 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Gremaud, A. L. et al. Gamifying accelerometer use increases physical activity levels of sedentary office workers. J. Am. Heart Assoc. https://doi.org/10.1161/JAHA.117.007735 (2018).

    Article 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Church, T. S. et al. Trends over 5 decades in U.S. occupation-related physical activity and their associations with obesity. PLoS ONE 6, e19657 (2011).

    Article 
    CAS 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Parikh, N. I. et al. Increasing trends in incidence of overweight and obesity over 5 decades. Am. J. Med. 120, 242–250 (2007).

    Article 
    PubMed 

    Google Scholar
     

  • Liu, P. H. et al. Association of obesity with risk of early-onset colorectal cancer among women. JAMA Oncol. 5, 37–44 (2019).

    Article 
    PubMed 

    Google Scholar
     

  • Li, H. et al. Associations of body mass index at different ages with early-onset colorectal cancer. Gastroenterology 162, 1088–1097.e3 (2022).

    Article 
    PubMed 

    Google Scholar
     

  • Murphy, C. C. et al. Maternal obesity, pregnancy weight gain, and birth weight and risk of colorectal cancer. Gut 71, 1332–1339 (2022).

    Article 
    PubMed 

    Google Scholar
     

  • Ali Khan, U. et al. Personal history of diabetes as important as family history of colorectal cancer for risk of colorectal cancer: a nationwide cohort study. Am. J. Gastroenterol. 115, 1103–1109 (2020).

    Article 
    PubMed 

    Google Scholar
     

  • Jasperson, K. W., Tuohy, T. M., Neklason, D. W. & Burt, R. W. Hereditary and familial colon cancer. Gastroenterology 138, 2044–2058 (2010).

    Article 
    CAS 
    PubMed 

    Google Scholar
     

  • Patel, S. G., Karlitz, J. J., Yen, T., Lieu, C. H. & Boland, C. R. The rising tide of early-onset colorectal cancer: a comprehensive review of epidemiology, clinical features, biology, risk factors, prevention, and early detection. Lancet Gastroenterol. Hepatol. 7, 262–274 (2022).

    Article 
    PubMed 

    Google Scholar
     

  • Stoffel, E. M. et al. Germline genetic features of young individuals with colorectal cancer. Gastroenterology 154, 897–905.e1 (2018).

    Article 
    CAS 
    PubMed 

    Google Scholar
     

  • Pearlman, R. et al. Prevalence and spectrum of germline cancer susceptibility gene mutations among patients with early-onset colorectal cancer. JAMA Oncol. 3, 464–471 (2017).

    Article 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Kim, J. E. et al. High prevalence of TP53 loss and whole-genome doubling in early-onset colorectal cancer. Exp. Mol. Med. 53, 446–456 (2021).

    Article 
    CAS 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Mauri, G. et al. Early-onset colorectal cancer in young individuals. Mol. Oncol. 13, 109–131 (2019).

    Article 
    PubMed 

    Google Scholar
     

  • Sanz-Garcia, E., Argiles, G., Elez, E. & Tabernero, J. BRAF mutant colorectal cancer: prognosis, treatment, and new perspectives. Ann. Oncol. 28, 2648–2657 (2017).

    Article 
    CAS 
    PubMed 

    Google Scholar
     

  • Haigis, K. M. et al. Differential effects of oncogenic K-Ras and N-Ras on proliferation, differentiation and tumor progression in the colon. Nat. Genet. 40, 600–608 (2008).

    Article 
    CAS 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Perea, J. et al. Frequency and impact of KRAS mutation in early onset colorectal cancer. Hum. Pathol. 61, 221–222 (2017).

    Article 
    CAS 
    PubMed 

    Google Scholar
     

  • Colon Cancer Laparoscopic or Open Resection Study Group. Survival after laparoscopic surgery versus open surgery for colon cancer: long-term outcome of a randomised clinical trial. Lancet Oncol. 10, 44–52 (2009).

    Article 
    PubMed 

    Google Scholar
     

  • Ugai, T. et al. Molecular characteristics of early-onset colorectal cancer according to detailed anatomical locations: comparison with later-onset cases. Am. J. Gastroenterol. https://doi.org/10.14309/ajg.0000000000002171 (2023).

    Article 
    PubMed 

    Google Scholar
     

  • Perea, J. et al. Age at onset should be a major criterion for subclassification of colorectal cancer. J. Mol. Diagn. 16, 116–126 (2014).

    Article 
    CAS 
    PubMed 

    Google Scholar
     

  • Stigliano, V., Sanchez-Mete, L., Martayan, A. & Anti, M. Early-onset colorectal cancer: a sporadic or inherited disease? World J. Gastroenterol. 20, 12420–12430 (2014).

    Article 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Islami, F. et al. Proportion and number of cancer cases and deaths attributable to potentially modifiable risk factors in the United States. CA Cancer J. Clin. 68, 31–54 (2018).

    Article 
    PubMed 

    Google Scholar
     

  • Bouvard, V. et al. Carcinogenicity of consumption of red and processed meat. Lancet Oncol. 16, 1599–1600 (2015).

    Article 
    PubMed 

    Google Scholar
     

  • Domingo, J. L. & Nadal, M. Carcinogenicity of consumption of red meat and processed meat: a review of scientific news since the IARC decision. Food Chem. Toxicol. 105, 256–261 (2017).

    Article 
    CAS 
    PubMed 

    Google Scholar
     

  • Fahrer, J. & Kaina, B. Impact of DNA repair on the dose-response of colorectal cancer formation induced by dietary carcinogens. Food Chem. Toxicol. 106, 583–594 (2017).

    Article 
    CAS 
    PubMed 

    Google Scholar
     

  • Hammerling, U., Bergman Laurila, J., Grafstrom, R. & Ilback, N. G. Consumption of red/processed meat and colorectal carcinoma: possible mechanisms underlying the significant association. Crit. Rev. Food Sci. Nutr. 56, 614–634 (2016).

    Article 
    CAS 
    PubMed 

    Google Scholar
     

  • Johnson, C. H. et al. Molecular mechanisms of alcohol-induced colorectal carcinogenesis. Cancers https://doi.org/10.3390/cancers13174404 (2021).

    Article 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Grega, T., Vojtechova, G., Gregova, M., Zavoral, M. & Suchanek, S. Pathophysiological characteristics linking type 2 diabetes mellitus and colorectal neoplasia. Physiol. Res. 70, 509–522 (2021).

    Article 
    CAS 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Deng, T., Lyon, C. J., Bergin, S., Caligiuri, M. A. & Hsueh, W. A. Obesity, inflammation, and cancer. Annu. Rev. Pathol. 11, 421–449 (2016).

    Article 
    CAS 
    PubMed 

    Google Scholar
     

  • Tarasiuk, A., Mosinska, P. & Fichna, J. The mechanisms linking obesity to colon cancer: an overview. Obes. Res. Clin. Pract. 12, 251–259 (2018).

    Article 
    PubMed 

    Google Scholar
     

  • Avgerinos, K. I., Spyrou, N., Mantzoros, C. S. & Dalamaga, M. Obesity and cancer risk: emerging biological mechanisms and perspectives. Metabolism 92, 121–135 (2019).

    Article 
    CAS 
    PubMed 

    Google Scholar
     

  • Yang, Y. et al. Fusobacterium nucleatum increases proliferation of colorectal cancer cells and tumor development in mice by activating toll-like receptor 4 signaling to nuclear factor-κB, and up-regulating expression of microRNA-21. Gastroenterology 152, 851–866.e24 (2017).

    Article 
    CAS 
    PubMed 

    Google Scholar
     

  • Chen, Y. et al. Invasive Fusobacterium nucleatum activates beta-catenin signaling in colorectal cancer via a TLR4/P-PAK1 cascade. Oncotarget 8, 31802–31814 (2017).

    Article 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Peek, R. M. Jr & Blaser, M. J. Helicobacter pylori and gastrointestinal tract adenocarcinomas. Nat. Rev. Cancer 2, 28–37 (2002).

    Article 
    CAS 
    PubMed 

    Google Scholar
     

  • Islami, F. & Kamangar, F. Helicobacter pylori and esophageal cancer risk: a meta-analysis. Cancer Prev. Res. 1, 329–338 (2008).

    Article 
    CAS 

    Google Scholar
     

  • Francois, F. et al. The effect of H. pylori eradication on meal-associated changes in plasma ghrelin and leptin. BMC Gastroenterol. 11, 37 (2011).

    Article 
    CAS 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Anderson, W. F. et al. The changing face of noncardia gastric cancer incidence among US non-Hispanic whites. J. Natl Cancer Inst. 110, 608–615 (2018).

    Article 
    CAS 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Cao, Y. et al. Long-term use of antibiotics and risk of colorectal adenoma. Gut 67, 672–678 (2018).

    CAS 
    PubMed 

    Google Scholar
     

  • Aneke-Nash, C., Yoon, G., Du, M. & Liang, P. Antibiotic use and colorectal neoplasia: a systematic review and meta-analysis. BMJ Open Gastroenterol. https://doi.org/10.1136/bmjgast-2021-000601 (2021).

    Article 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Zhang, J. et al. Oral antibiotic use and risk of colorectal cancer in the United Kingdom, 1989-2012: a matched case-control study. Gut 68, 1971–1978 (2019).

    Article 
    CAS 
    PubMed 

    Google Scholar
     

  • Kilkkinen, A. et al. Antibiotic use predicts an increased risk of cancer. Int. J. Cancer 123, 2152–2155 (2008).

    Article 
    CAS 
    PubMed 

    Google Scholar
     

  • Boursi, B., Haynes, K., Mamtani, R. & Yang, Y. X. Impact of antibiotic exposure on the risk of colorectal cancer. Pharmacoepidemiol. Drug Saf. 24, 534–542 (2015).

    Article 
    CAS 
    PubMed 

    Google Scholar
     

  • Louis, P., Hold, G. L. & Flint, H. J. The gut microbiota, bacterial metabolites and colorectal cancer. Nat. Rev. Microbiol. 12, 661–672 (2014).

    Article 
    CAS 
    PubMed 

    Google Scholar
     

  • Ternes, D. et al. The gut microbial metabolite formate exacerbates colorectal cancer progression. Nat. Metab. 4, 458–475 (2022).

    Article 
    CAS 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Wu, H. J. & Wu, E. The role of gut microbiota in immune homeostasis and autoimmunity. Gut Microbes 3, 4–14 (2012).

    Article 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Zheng, D., Liwinski, T. & Elinav, E. Interaction between microbiota and immunity in health and disease. Cell Res. 30, 492–506 (2020).

    Article 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • David, L. A. et al. Diet rapidly and reproducibly alters the human gut microbiome. Nature 505, 559–563 (2014).

    Article 
    CAS 
    PubMed 

    Google Scholar
     

  • Ahmad Kendong, S. M., Raja Ali, R. A., Nawawi, K. N. M., Ahmad, H. F. & Mokhtar, N. M. Gut dysbiosis and intestinal barrier dysfunction: potential explanation for early-onset colorectal cancer. Front. Cell Infect. Microbiol. 11, 744606 (2021).

    Article 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Abed, J. et al. Colon cancer-associated Fusobacterium nucleatum may originate from the oral cavity and reach colon tumors via the circulatory system. Front. Cell Infect. Microbiol. 10, 400 (2020).

    Article 
    CAS 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Sears, C. L. The who, where and how of fusobacteria and colon cancer. Elife https://doi.org/10.7554/eLife.28434 (2018).

    Article 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Chen, T. et al. TOX expression decreases with progression of colorectal cancers and is associated with CD4 T-cell density and Fusobacterium nucleatum infection. Hum. Pathol. 79, 93–101 (2018).

    Article 
    CAS 
    PubMed 

    Google Scholar
     

  • Wu, J., Li, Q. & Fu, X. Fusobacterium nucleatum contributes to the carcinogenesis of colorectal cancer by inducing inflammation and suppressing host immunity. Transl Oncol. 12, 846–851 (2019).

    Article 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Rubinstein, M. R. et al. Fusobacterium nucleatum promotes colorectal carcinogenesis by modulating E-cadherin/β-catenin signaling via its FadA adhesin. Cell Host Microbe 14, 195–206 (2013).

    Article 
    CAS 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Rubinstein, M. R. et al. Fusobacterium nucleatum promotes colorectal cancer by inducing Wnt/β-catenin modulator annexin A1. EMBO Rep. 20, e47638 (2019).

    Article 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Flanagan, L. et al. Fusobacterium nucleatum associates with stages of colorectal neoplasia development, colorectal cancer and disease outcome. Eur. J. Clin. Microbiol. Infect. Dis. 33, 1381–1390 (2014).

    Article 
    CAS 
    PubMed 

    Google Scholar
     

  • Kaper, J. B., Nataro, J. P. & Mobley, H. L. Pathogenic Escherichia coli. Nat. Rev. Microbiol. 2, 123–140 (2004).

    Article 
    CAS 
    PubMed 

    Google Scholar
     

  • Homburg, S., Oswald, E., Hacker, J. & Dobrindt, U. Expression analysis of the colibactin gene cluster coding for a novel polyketide in Escherichia coli. FEMS Microbiol. Lett. 275, 255–262 (2007).

    Article 
    CAS 
    PubMed 

    Google Scholar
     

  • Oliero, M. et al. Prevalence of pks + bacteria and enterotoxigenic Bacteroides fragilis in patients with colorectal cancer. Gut Pathog. 14, 51 (2022).

    Article 
    CAS 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Lee-Six, H. et al. The landscape of somatic mutation in normal colorectal epithelial cells. Nature 574, 532–537 (2019).

    Article 
    CAS 
    PubMed 

    Google Scholar
     

  • Chubb, D. et al. Rare disruptive mutations and their contribution to the heritable risk of colorectal cancer. Nat. Commun. 7, 11883 (2016).

    Article 
    CAS 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Archambault, A. N. et al. Cumulative burden of colorectal cancer-associated genetic variants is more strongly associated with early-onset vs late-onset cancer. Gastroenterology 158, 1274–1286.e12 (2020).

    Article 
    CAS 
    PubMed 

    Google Scholar
     

  • Huyghe, J. R. et al. Discovery of common and rare genetic risk variants for colorectal cancer. Nat. Genet. 51, 76–87 (2019).

    Article 
    CAS 
    PubMed 

    Google Scholar
     

  • You, Y. N. et al. Germline cancer risk profiles of young-onset colorectal cancer patients: findings from a prospective universal germline testing and tele-genetics program. Dis. Colon Rectum https://doi.org/10.1097/DCR.0000000000002347 (2022).

    Article 
    PubMed 

    Google Scholar
     

  • Boardman, L. A., Vilar, E., You, Y. N. & Samadder, J. AGA clinical practice update on young adult-onset colorectal cancer diagnosis and management: expert review. Clin. Gastroenterol. Hepatol. 18, 2415–2424 (2020).

    Article 
    CAS 
    PubMed 

    Google Scholar
     

  • Provenzale, D. et al. NCCN Guidelines Insights: colorectal cancer screening, version 1.2018. J. Natl Compr. Canc. Netw. 16, 939–949 (2018).

    Article 
    PubMed 

    Google Scholar
     

  • Valle, L., Vilar, E., Tavtigian, S. V. & Stoffel, E. M. Genetic predisposition to colorectal cancer: syndromes, genes, classification of genetic variants and implications for precision medicine. J. Pathol. 247, 574–588 (2019).

    Article 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Ma, H. et al. Pathology and genetics of hereditary colorectal cancer. Pathology 50, 49–59 (2018).

    Article 
    CAS 
    PubMed 

    Google Scholar
     

  • Willauer, A. N. et al. Clinical and molecular characterization of early-onset colorectal cancer. Cancer 125, 2002–2010 (2019).

    Article 
    CAS 
    PubMed 

    Google Scholar
     

  • Broderick, P. et al. Evaluation of NTHL1, NEIL1, NEIL2, MPG, TDG, UNG and SMUG1 genes in familial colorectal cancer predisposition. BMC Cancer 6, 243 (2006).

    Article 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Yurgelun, M. B. et al. Cancer susceptibility gene mutations in individuals with colorectal cancer. J. Clin. Oncol. 35, 1086–1095 (2017).

    Article 
    CAS 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • LaDuca, H. et al. A clinical guide to hereditary cancer panel testing: evaluation of gene-specific cancer associations and sensitivity of genetic testing criteria in a cohort of 165,000 high-risk patients. Genet. Med. 22, 407–415 (2020).

    Article 
    CAS 
    PubMed 

    Google Scholar
     

  • Mork, M. E. et al. High prevalence of hereditary cancer syndromes in adolescents and young adults with colorectal cancer. J. Clin. Oncol. 33, 3544–3549 (2015).

    Article 
    CAS 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Zhunussova, G. et al. Mutation spectrum of cancer-associated genes in patients with early onset of colorectal cancer. Front. Oncol. 9, 673 (2019).

    Article 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • You, Y. N. et al. Detection of pathogenic germline variants among patients with advanced colorectal cancer undergoing tumor genomic profiling for precision medicine. Dis. Colon Rectum 62, 429–437 (2019).

    Article 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Mork, M. E. et al. Outcomes of disease-specific next-generation sequencing gene panel testing in adolescents and young adults with colorectal cancer. Cancer Genet. 235–236, 77–83 (2019).

    Article 
    PubMed 

    Google Scholar
     

  • Tutlewska, K., Lubinski, J. & Kurzawski, G. Germline deletions in the EPCAM gene as a cause of Lynch syndrome – literature review. Hered. Cancer Clin. Pract. 11, 9 (2013).

    Article 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Ligtenberg, M. J. et al. Heritable somatic methylation and inactivation of MSH2 in families with Lynch syndrome due to deletion of the 3′ exons of TACSTD1. Nat. Genet. 41, 112–117 (2009).

    Article 
    CAS 
    PubMed 

    Google Scholar
     

  • Edelstein, D. L. et al. Rapid development of colorectal neoplasia in patients with Lynch syndrome. Clin. Gastroenterol. Hepatol. 9, 340–343 (2011).

    Article 
    PubMed 

    Google Scholar
     

  • Vasen, H. F. Review article: the Lynch syndrome (hereditary nonpolyposis colorectal cancer). Aliment. Pharmacol. Ther. 26 (Suppl. 2), 113–126 (2007).

    Article 
    CAS 
    PubMed 

    Google Scholar
     

  • Valle, L. Genetic predisposition to colorectal cancer: where we stand and future perspectives. World J. Gastroenterol. 20, 9828–9849 (2014).

    Article 
    CAS 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Aelvoet, A. S., Buttitta, F., Ricciardiello, L. & Dekker, E. Management of familial adenomatous polyposis and MUTYH-associated polyposis; new insights. Best. Pract. Res. Clin. Gastroenterol. 58–59, 101793 (2022).

    Article 
    PubMed 

    Google Scholar
     

  • Peterse, E. F. P. et al. The impact of the rising colorectal cancer incidence in young adults on the optimal age to start screening: microsimulation analysis I to inform the American Cancer Society colorectal cancer screening guideline. Cancer 124, 2964–2973 (2018).

    Article 
    PubMed 

    Google Scholar
     

  • Giardiello, F. M. et al. Guidelines on genetic evaluation and management of Lynch syndrome: a consensus statement by the US Multi-society Task Force on colorectal cancer. Am. J. Gastroenterol. 109, 1159–1179 (2014).

    Article 
    PubMed 

    Google Scholar
     

  • Knudsen, A. B. et al. Colorectal Cancer Screening: An Updated Decision Analysis for the U.S. Preventive Services Task Force. Report No. 20-05271-EF-2 (Agency for Healthcare Research and Quality, 2021).

  • Ko, C. W. et al. AGA Clinical Practice Guidelines on the gastrointestinal evaluation of iron deficiency anemia. Gastroenterology 159, 1085–1094 (2020).

    Article 
    PubMed 

    Google Scholar
     

  • Vajravelu, R. K., Mehta, S. J. & Lewis, J. D., Early-age Onset Colorectal Cancer Testing, Epidemiology, Diagnosis, and Symptoms Study Group. Understanding characteristics of who undergoes testing is crucial for the development of diagnostic strategies to identify individuals at risk for early-age onset colorectal cancer. Gastroenterology 160, 993–998 (2021).

    Article 
    PubMed 

    Google Scholar
     

  • Low, E. E. et al. Risk factors for early-onset colorectal cancer. Gastroenterology 159, 492–501.e7 (2020).

    Article 
    CAS 
    PubMed 

    Google Scholar
     

  • Syed, A. R. et al. Old vs new: risk factors predicting early onset colorectal cancer. World J. Gastrointest. Oncol. 11, 1011–1020 (2019).

    Article 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Frostberg, E. & Rahr, H. B. Clinical characteristics and a rising incidence of early-onset colorectal cancer in a nationwide cohort of 521 patients aged 18-40 years. Cancer Epidemiol. 66, 101704 (2020).

    Article 
    PubMed 

    Google Scholar
     

  • Krigel, A., Zhou, M., Terry, M. B., Kastrinos, F. & Lebwohl, B. Symptoms and demographic factors associated with early-onset colorectal neoplasia among individuals undergoing diagnostic colonoscopy. Eur. J. Gastroenterol. Hepatol. 32, 821–826 (2020).

    Article 
    PubMed 

    Google Scholar
     

  • Dozois, E. J. et al. Young-onset colorectal cancer in patients with no known genetic predisposition: can we increase early recognition and improve outcome? Medicine 87, 259–263 (2008).

    Article 
    PubMed 

    Google Scholar
     

  • Glover, M., Mansoor, E., Panhwar, M., Parasa, S. & Cooper, G. S. Epidemiology of colorectal cancer in average risk adults 20–39 years of age: a population-based national study. Dig. Dis. Sci. 64, 3602–3609 (2019).

    Article 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Di Leo, M. et al. Risk factors and clinical characteristics of early-onset colorectal cancer vs. late-onset colorectal cancer: a case-case study. Eur. J. Gastroenterol. Hepatol. 33, 1153–1160 (2021).

    Article 
    PubMed 

    Google Scholar
     

  • Kuipers, E. J. et al. Colorectal cancer. Nat. Rev. Dis. Primers 1, 15065 (2015).

    Article 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Schreuders, E. H. et al. Colorectal cancer screening: a global overview of existing programmes. Gut 64, 1637–1649 (2015).

    Article 
    PubMed 

    Google Scholar
     

  • World Health Organization. Colorectal Cancer Screening. IARC Handbooks of Cancer Prevention Vol. 17 (IARC, 2019).

  • Rex, D. K. et al. Colorectal cancer screening: recommendations for physicians and patients from the U.S. multi-society task force on colorectal cancer. Am. J. Gastroenterol. 112, 1016–1030 (2017).

    Article 
    PubMed 

    Google Scholar
     

  • Patel, S. G. et al. Updates on age to start and stop colorectal cancer screening: recommendations from the U.S. multi-society task force on colorectal cancer. Gastroenterology 162, 285–299 (2022).

    Article 
    PubMed 

    Google Scholar
     

  • Wolf, A. M. D. et al. Colorectal cancer screening for average-risk adults: 2018 guideline update from the American Cancer Society. CA Cancer J. Clin. 68, 250–281 (2018).

    Article 
    PubMed 

    Google Scholar
     

  • Davidson, K. W. et al. Screening for colorectal cancer: US Preventive Services Task Force recommendation statement. JAMA 325, 1965–1977 (2021).

    Article 
    PubMed 

    Google Scholar
     

  • Kalyta, A. et al. Canadian colorectal cancer screening guidelines: do they need an update given changing incidence and global practice patterns. Curr. Oncol. 28, 1558–1570 (2021).

    Article 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Sung, J. J. Y. et al. Third Asia Pacific consensus recommendation on colorectal cancer screening and postpolypectomy surveillance. Gut 71, 2152–2166 (2022).

    Article 
    PubMed 

    Google Scholar
     

  • Ladabaum, U., Mannalithara, A., Meester, R. G. S., Gupta, S. & Schoen, R. E. Cost-effectiveness and national effects of initiating colorectal cancer screening for average-risk persons at age 45 years instead of 50 years. Gastroenterology 157, 137–148 (2019).

    Article 
    PubMed 

    Google Scholar
     

  • Ladabaum, U., Dominitz, J. A., Kahi, C. & Schoen, R. E. Strategies for colorectal cancer screening. Gastroenterology 158, 418–432 (2020).

    Article 
    CAS 
    PubMed 

    Google Scholar
     

  • Knudsen, A. B. et al. Colorectal cancer screening: an updated modeling study for the US Preventive Services Task Force. JAMA 325, 1998–2011 (2021).

    Article 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Lew, J. B. et al. Benefits, harms, and cost-effectiveness of potential age extensions to the national bowel cancer screening program in Australia. Cancer Epidemiol. Biomark. Prev. 27, 1450–1461 (2018).

    Article 

    Google Scholar
     

  • Hampel, H. et al. Feasibility of screening for Lynch syndrome among patients with colorectal cancer. J. Clin. Oncol. 26, 5783–5788 (2008).

    Article 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Snowsill, T. et al. A model-based assessment of the cost-utility of strategies to identify Lynch syndrome in early-onset colorectal cancer patients. BMC Cancer 15, 313 (2015).

    Article 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Snowsill, T. et al. Molecular testing for Lynch syndrome in people with colorectal cancer: systematic reviews and economic evaluation. Health Technol. Assess. 21, 1–238 (2017).

    Article 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Syngal, S. et al. ACG clinical guideline: genetic testing and management of hereditary gastrointestinal cancer syndromes. Am. J. Gastroenterol. 110, 223–262 (2015).

    Article 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Hunter, J. E. et al. Universal screening for Lynch syndrome among patients with colorectal cancer: patient perspectives on screening and sharing results with at-risk relatives. Fam. Cancer 16, 377–387 (2017).

    Article 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Clarke, E. V. et al. Implementation of a systematic tumor screening program for Lynch syndrome in an integrated health care setting. Fam. Cancer 18, 317–325 (2019).

    Article 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Papke, D. J., Lindeman, N. I., Schrag, D. & Iorgulescu, J. B. Underutilization of guideline-recommended mismatch repair/microsatellite instability biomarker testing in advanced colorectal cancer. Cancer Epidemiol. Biomark. Prev. 31, 1746–1751 (2022).

    Article 

    Google Scholar
     

  • Mei, W. J. et al. Clinicopathological characteristics of high microsatellite instability/mismatch repair-deficient colorectal cancer: a narrative review. Front. Immunol. 13, 1019582 (2022).

    Article 
    CAS 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Evaluation of Genomic Applications in Practice and Prevention (EGAPP) Working Group. Recommendations from the EGAPP Working Group: genetic testing strategies in newly diagnosed individuals with colorectal cancer aimed at reducing morbidity and mortality from Lynch syndrome in relatives. Genet. Med. 11, 35–41 (2009).

    Article 

    Google Scholar
     

  • Beard, V. K. et al. Genetic testing in families with hereditary colorectal cancer in British Columbia and Yukon: a retrospective cross-sectional analysis. CMAJ Open 8, E637–E642 (2020).

    Article 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Bednar, E. M., Sun, C. C., McCurdy, S. & Vernon, S. W. Assessing relatives’ readiness for hereditary cancer cascade genetic testing. Genet. Med. 22, 719–726 (2020).

    Article 
    PubMed 

    Google Scholar
     

  • Ponz de Leon, M. et al. Genetic testing among high-risk individuals in families with hereditary nonpolyposis colorectal cancer. Br. J. Cancer 90, 882–887 (2004).

    Article 
    CAS 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Koehly, L. M. et al. A social network analysis of communication about hereditary nonpolyposis colorectal cancer genetic testing and family functioning. Cancer Epidemiol. Biomark. Prev. 12, 304–313 (2003).


    Google Scholar
     

  • McGivern, B. et al. Family communication about positive BRCA1 and BRCA2 genetic test results. Genet. Med. 6, 503–509 (2004).

    Article 
    CAS 
    PubMed 

    Google Scholar
     

  • Sanz, J. et al. Uptake of predictive testing among relatives of BRCA1 and BRCA2 families: a multicenter study in northeastern Spain. Fam. Cancer 9, 297–304 (2010).

    Article 
    PubMed 

    Google Scholar
     

  • Stoffel, E. M. et al. Sharing genetic test results in Lynch syndrome: communication with close and distant relatives. Clin. Gastroenterol. Hepatol. 6, 333–338 (2008).

    Article 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Whitaker, K. D., Obeid, E., Daly, M. B. & Hall, M. J. Cascade genetic testing for hereditary cancer risk: an underutilized tool for cancer prevention. JCO Precis. Oncol. 5, 1387–1396 (2021).

    Article 
    PubMed 

    Google Scholar
     

  • Forrest, K. et al. To tell or not to tell: barriers and facilitators in family communication about genetic risk. Clin. Genet. 64, 317–326 (2003).

    Article 
    CAS 
    PubMed 

    Google Scholar
     

  • Stoffel, E. M. Cascade genetic testing in families with Lynch syndrome. MiGRC https://migrc.org/resource/cascade-genetic-testing-in-families-with-lynch-syndrome/ (2016).

  • George, R., Kovak, K. & Cox, S. L. Aligning policy to promote cascade genetic screening for prevention and early diagnosis of heritable diseases. J. Genet. Couns. 24, 388–399 (2015).

    Article 
    PubMed 

    Google Scholar
     

  • Menko, F. H. et al. The uptake of presymptomatic genetic testing in hereditary breast-ovarian cancer and Lynch syndrome: a systematic review of the literature and implications for clinical practice. Fam. Cancer 18, 127–135 (2019).

    Article 
    CAS 
    PubMed 

    Google Scholar
     

  • Hann, K. E. J. et al. Awareness, knowledge, perceptions, and attitudes towards genetic testing for cancer risk among ethnic minority groups: a systematic review. BMC Public Health 17, 503 (2017).

    Article 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Srinivasan, S. et al. Stakeholder perspectives on overcoming barriers to cascade testing in Lynch syndrome: a qualitative study. Cancer Prev. Res. 13, 1037–1046 (2020).

    Article 

    Google Scholar
     

  • Whitworth, P. et al. Impact of payer constraints on access to genetic testing. J. Oncol. Pract. 13, e47–e56 (2017).

    Article 
    PubMed 

    Google Scholar
     

  • Radford, C., Prince, A., Lewis, K. & Pal, T. Factors which impact the delivery of genetic risk assessment services focused on inherited cancer genomics: expanding the role and reach of certified genetics professionals. J. Genet. Couns. 23, 522–530 (2014).

    Article 
    PubMed 

    Google Scholar
     

  • Gustafson, S. L., Pfeiffer, G. & Eng, C. A large health system’s approach to utilization of the genetic counselor CPT(R) 96040 code. Genet. Med. 13, 1011–1014 (2011).

    Article 
    PubMed 

    Google Scholar
     

  • Møller, P. et al. Cancer risk and survival in path_MMR carriers by gene and gender up to 75 years of age: a report from the prospective Lynch Syndrome Database. Gut 67, 1306–1316 (2018).

    Article 
    PubMed 

    Google Scholar
     

  • Plaschke, J. et al. Lower incidence of colorectal cancer and later age of disease onset in 27 families with pathogenic MSH6 germline mutations compared with families with MLH1 or MSH2 mutations: the German Hereditary Nonpolyposis Colorectal Cancer Consortium. J. Clin. Oncol. 22, 4486–4494 (2004).

    Article 
    CAS 
    PubMed 

    Google Scholar
     

  • Dominguez-Valentin, M. et al. Cancer risks by gene, age, and gender in 6350 carriers of pathogenic mismatch repair variants: findings from the Prospective Lynch Syndrome Database. Genet. Med. 22, 15–25 (2020).

    Article 
    CAS 
    PubMed 

    Google Scholar
     

  • Hendriks, Y. M. et al. Cancer risk in hereditary nonpolyposis colorectal cancer due to MSH6 mutations: impact on counseling and surveillance. Gastroenterology 127, 17–25 (2004).

    Article 
    CAS 
    PubMed 

    Google Scholar
     

  • Monahan, K. J. et al. Guidelines for the management of hereditary colorectal cancer from the British Society of Gastroenterology (BSG)/Association of Coloproctology of Great Britain and Ireland (ACPGBI)/United Kingdom Cancer Genetics Group (UKCGG). Gut 69, 411–444 (2020).

    Article 
    CAS 
    PubMed 

    Google Scholar
     

  • van Leerdam, M. E. et al. Endoscopic management of Lynch syndrome and of familial risk of colorectal cancer: European Society of Gastrointestinal Endoscopy (ESGE) guideline. Endoscopy 51, 1082–1093 (2019).

    Article 
    PubMed 

    Google Scholar
     

  • Jarvinen, H. J. et al. Controlled 15-year trial on screening for colorectal cancer in families with hereditary nonpolyposis colorectal cancer. Gastroenterology 118, 829–834 (2000).

    Article 
    CAS 
    PubMed 

    Google Scholar
     

  • Renkonen-Sinisalo, L., Aarnio, M., Mecklin, J. P. & Jarvinen, H. J. Surveillance improves survival of colorectal cancer in patients with hereditary nonpolyposis colorectal cancer. Cancer Detect. Prev. 24, 137–142 (2000).

    CAS 
    PubMed 

    Google Scholar
     

  • Barrow, P., Khan, M., Lalloo, F., Evans, D. G. & Hill, J. Systematic review of the impact of registration and screening on colorectal cancer incidence and mortality in familial adenomatous polyposis and Lynch syndrome. Br. J. Surg. 100, 1719–1731 (2013).

    Article 
    CAS 
    PubMed 

    Google Scholar
     

  • Goverde, A. et al. Routine molecular analysis for Lynch syndrome among adenomas or colorectal cancer within a national screening program. Gastroenterology 155, 1410–1415 (2018).

    Article 
    PubMed 

    Google Scholar
     

  • Vasen, H. F. et al. Guidelines for the clinical management of familial adenomatous polyposis (FAP). Gut 57, 704–713 (2008).

    Article 
    CAS 
    PubMed 

    Google Scholar
     

  • Björk, J. A., Akerbrant, H. I., Iselius, L. E. & Hultcrantz, R. W. Risk factors for rectal cancer morbidity and mortality in patients with familial adenomatous polyposis after colectomy and ileorectal anastomosis. Dis. Colon Rectum 43, 1719–1725 (2000).

    Article 
    PubMed 

    Google Scholar
     

  • Heiskanen, I., Luostarinen, T. & Jarvinen, H. J. Impact of screening examinations on survival in familial adenomatous polyposis. Scand. J. Gastroenterol. 35, 1284–1287 (2000).

    Article 
    CAS 
    PubMed 

    Google Scholar
     

  • Burt, R. W. et al. Genetic testing and phenotype in a large kindred with attenuated familial adenomatous polyposis. Gastroenterology 127, 444–451 (2004).

    Article 
    PubMed 

    Google Scholar
     

  • Leenen, C. H. et al. Cost-effectiveness of routine screening for Lynch syndrome in colorectal cancer patients up to 70 years of age. Genet. Med. 18, 966–973 (2016).

    Article 
    PubMed 

    Google Scholar
     

  • LoConte, N. K. et al. Lifestyle modifications and policy implications for primary and secondary cancer prevention: diet, exercise, sun safety, and alcohol reduction. Am. Soc. Clin. Oncol. Educ. Book. 38, 88–100 (2018).

    Article 
    PubMed 

    Google Scholar
     

  • US Department of Health and Human Services. Physical activity guidelines for Americans, 2nd edition. US Department of Health and Human Services https://health.gov/sites/default/files/2019-09/Physical_Activity_Guidelines_2nd_edition.pdf (2018).

  • Farinetti, A., Zurlo, V., Manenti, A., Coppi, F. & Mattioli, A. V. Mediterranean diet and colorectal cancer: a systematic review. Nutrition 43-44, 83–88 (2017).

    Article 
    CAS 
    PubMed 

    Google Scholar
     

  • Cao, Y. et al. Population-wide impact of long-term use of aspirin and the risk for cancer. JAMA Oncol. 2, 762–769 (2016).

    Article 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Oruc, Z. & Kaplan, M. A. Effect of exercise on colorectal cancer prevention and treatment. World J. Gastrointest. Oncol. 11, 348–366 (2019).

    Article 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Durko, L. & Malecka-Panas, E. Lifestyle modifications and colorectal cancer. Curr. Colorectal Cancer Rep. 10, 45–54 (2014).

    Article 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Derry, M. M., Raina, K., Agarwal, C. & Agarwal, R. Identifying molecular targets of lifestyle modifications in colon cancer prevention. Front. Oncol. 3, 119 (2013).

    Article 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Chan, D. S. et al. Red and processed meat and colorectal cancer incidence: meta-analysis of prospective studies. PLoS ONE 6, e20456 (2011).

    Article 
    CAS 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Sugimura, T., Wakabayashi, K., Nakagama, H. & Nagao, M. Heterocyclic amines: mutagens/carcinogens produced during cooking of meat and fish. Cancer Sci. 95, 290–299 (2004).

    Article 
    CAS 
    PubMed 

    Google Scholar
     

  • Aune, D. et al. Dietary fibre, whole grains, and risk of colorectal cancer: systematic review and dose-response meta-analysis of prospective studies. BMJ 343, d6617 (2011).

    Article 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Bingham, S. A. et al. Dietary fibre in food and protection against colorectal cancer in the European prospective investigation into cancer and nutrition (EPIC): an observational study. Lancet 361, 1496–1501 (2003).

    Article 
    PubMed 

    Google Scholar
     

  • Yue, Y. et al. Prospective evaluation of dietary and lifestyle pattern indices with risk of colorectal cancer in a cohort of younger women. Ann. Oncol. 32, 778–786 (2021).

    Article 
    CAS 
    PubMed 

    Google Scholar
     

  • de Beer, J. C. & Liebenberg, L. Does cancer risk increase with HbA1c, independent of diabetes? Br. J. Cancer 110, 2361–2368 (2014).

    Article 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Cavestro, G. M. et al. Delphi initiative for early-onset colorectal cancer (DIRECt) international management guidelines. Clin. Gastroenterol. Hepatol. https://doi.org/10.1016/j.cgh.2022.12.006 (2022).

    Article 
    PubMed 

    Google Scholar
     

  • Tanaka, S. et al. JGES guidelines for colorectal endoscopic submucosal dissection/endoscopic mucosal resection. Dig. Endosc. 27, 417–434 (2015).

    Article 
    PubMed 

    Google Scholar
     

  • Pimentel-Nunes, P. et al. Endoscopic submucosal dissection: European Society of Gastrointestinal Endoscopy (ESGE) Guideline. Endoscopy 47, 829–854 (2015).

    Article 
    PubMed 

    Google Scholar
     

  • Draganov, P. V., Wang, A. Y., Othman, M. O. & Fukami, N. AGA Institute clinical practice update: endoscopic submucosal dissection in the United States. Clin. Gastroenterol. Hepatol. 17, 16–25.e1 (2019).

    Article 
    PubMed 

    Google Scholar
     

  • Kuellmer, A. et al. Endoscopic full-thickness resection for early colorectal cancer. Gastrointest. Endosc. 89, 1180–1189.e1 (2019).

    Article 
    PubMed 

    Google Scholar
     

  • Costas-Chavarri, A. et al. Treatment of patients with early-stage colorectal cancer: ASCO resource-stratified guideline. J. Glob. Oncol. 5, 1–19 (2019).

    PubMed 

    Google Scholar
     

  • Labianca, R. et al. Early colon cancer: ESMO clinical practice guidelines for diagnosis, treatment and follow-up. Ann. Oncol. 24 (Suppl. 6), vi64–vi72 (2013).

    Article 
    PubMed 

    Google Scholar
     

  • Heald, R. J. The ‘holy plane’ of rectal surgery. J. R. Soc. Med. 81, 503–508 (1988).

    Article 
    CAS 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Emmanuel, A. & Haji, A. Complete mesocolic excision and extended (D3) lymphadenectomy for colonic cancer: is it worth that extra effort? A review of the literature. Int. J. Colorectal Dis. 31, 797–804 (2016).

    Article 
    PubMed 

    Google Scholar
     

  • Kanemitsu, Y. et al. Primary tumor resection plus chemotherapy versus chemotherapy alone for colorectal cancer patients with asymptomatic, synchronous unresectable metastases (JCOG1007; iPACS): a randomized clinical trial. J. Clin. Oncol. 39, 1098–1107 (2021).

    Article 
    CAS 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Clinical Outcomes of Surgical Therapy Study Group. A comparison of laparoscopically assisted and open colectomy for colon cancer. N. Engl. J. Med. 350, 2050–2059 (2004).

    Article 

    Google Scholar
     

  • Carrato, A. Adjuvant treatment of colorectal cancer. Gastrointest. Cancer Res. 2, S42–S46 (2008).

    PubMed 
    PubMed Central 

    Google Scholar
     

  • Lieu, C. et al. Duration of oxaliplatin-containing adjuvant therapy for stage III colon cancer: ASCO clinical practice guideline. J. Clin. Oncol. 37, 1436–1447 (2019).

    Article 
    CAS 
    PubMed 

    Google Scholar
     

  • Grothey, A. et al. Duration of adjuvant chemotherapy for stage III colon cancer. N. Engl. J. Med. 378, 1177–1188 (2018).

    Article 
    CAS 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Van Cutsem, E. et al. ESMO consensus guidelines for the management of patients with metastatic colorectal cancer. Ann. Oncol. 27, 1386–1422 (2016).

    Article 
    PubMed 

    Google Scholar
     

  • Venook, A. P. et al. Effect of first-line chemotherapy combined with cetuximab or bevacizumab on overall survival in patients with KRAS wild-type advanced or metastatic colorectal cancer: a randomized clinical trial. JAMA 317, 2392–2401 (2017).

    Article 
    CAS 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Tabernero, J. et al. Encorafenib plus cetuximab as a new standard of care for previously treated BRAF V600E-mutant metastatic colorectal cancer: updated survival results and subgroup analyses from the BEACON study. J. Clin. Oncol. 39, 273–284 (2021).

    Article 
    CAS 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Arnold, D. et al. Prognostic and predictive value of primary tumour side in patients with RAS wild-type metastatic colorectal cancer treated with chemotherapy and EGFR directed antibodies in six randomized trials. Ann. Oncol. 28, 1713–1729 (2017).

    Article 
    CAS 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Yoshino, T. et al. Rationale for and design of the PARADIGM study: randomized phase III study of mFOLFOX6 plus bevacizumab or panitumumab in chemotherapy-naive patients with RAS (KRAS/NRAS) wild-type, metastatic colorectal cancer. Clin. Colorectal Cancer 16, 158–163 (2017).

    Article 
    PubMed 

    Google Scholar
     

  • Overman, M. J. et al. Durable clinical benefit with nivolumab plus ipilimumab in DNA mismatch repair-deficient/microsatellite instability-high metastatic colorectal cancer. J. Clin. Oncol. 36, 773–779 (2018).

    Article 
    CAS 
    PubMed 

    Google Scholar
     

  • Peacock, O. et al. Complications after extended radical resections for locally advanced and recurrent pelvic malignancies: a 25-year experience. Ann. Surg. Oncol. 27, 409–414 (2020).

    Article 
    PubMed 

    Google Scholar
     

  • You, Y. N. et al. The American Society of Colon and Rectal Surgeons clinical practice guidelines for the management of rectal cancer. Dis. Colon Rectum 63, 1191–1222 (2020).

    Article 
    PubMed 

    Google Scholar
     

  • Giordano, L. et al. Robotic-assisted and laparoscopic sigmoid resection. JSLS https://doi.org/10.4293/JSLS.2020.00028 (2020).

    Article 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Sauer, R. et al. Preoperative versus postoperative chemoradiotherapy for rectal cancer. N. Engl. J. Med. 351, 1731–1740 (2004).

    Article 
    CAS 
    PubMed 

    Google Scholar
     

  • Gerard, J. P. et al. Preoperative radiotherapy with or without concurrent fluorouracil and leucovorin in T3-4 rectal cancers: results of FFCD 9203. J. Clin. Oncol. 24, 4620–4625 (2006).

    Article 
    PubMed 

    Google Scholar
     

  • McCarthy, K., Pearson, K., Fulton, R. & Hewitt, J. Pre-operative chemoradiation for non-metastatic locally advanced rectal cancer. Cochrane Database Syst. Rev. 12, CD008368 (2012).

    PubMed 

    Google Scholar
     

  • Garcia-Aguilar, J. et al. Effect of adding mFOLFOX6 after neoadjuvant chemoradiation in locally advanced rectal cancer: a multicentre, phase 2 trial. Lancet Oncol. 16, 957–966 (2015).

    Article 
    CAS 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Garcia-Aguilar, J. et al. Organ preservation in patients with rectal adenocarcinoma treated with total neoadjuvant therapy. J. Clin. Oncol. 40, 2546–2556 (2022).

    Article 
    CAS 
    PubMed 

    Google Scholar
     

  • Yuval, J. B. & Garcia-Aguilar, J. Watch-and-wait management for rectal cancer after clinical complete response to neoadjuvant therapy. Adv. Surg. 55, 89–107 (2021).

    Article 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Weiser, M. R. et al. A dynamic clinical calculator for estimating conditional recurrence-free survival after total neoadjuvant therapy for rectal cancer and either surgery or watch-and-wait management. JAMA Netw. Open 5, e2233859 (2022).

    Article 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Stoffel, E. M. et al. Hereditary colorectal cancer syndromes: American Society of Clinical Oncology Clinical Practice Guideline endorsement of the familial risk-colorectal cancer: European Society for Medical Oncology Clinical Practice Guidelines. J. Clin. Oncol. 33, 209–217 (2015).

    Article 
    PubMed 

    Google Scholar
     

  • Herzig, D. et al. The American Society of Colon and Rectal Surgeons clinical practice guidelines for the management of inherited polyposis syndromes. Dis. Colon Rectum 60, 881–894 (2017).

    Article 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Herzig, D. O. et al. Clinical practice guidelines for the surgical treatment of patients with Lynch syndrome. Dis. Colon Rectum 60, 137–143 (2017).

    Article 
    PubMed 

    Google Scholar
     

  • Grothey, A. Pembrolizumab in MSI-H-dMMR advanced colorectal cancer – a new standard of care. N. Engl. J. Med. 383, 2283–2285 (2020).

    Article 
    CAS 
    PubMed 

    Google Scholar
     

  • Diaz, L. A. Jr et al. Pembrolizumab versus chemotherapy for microsatellite instability-high or mismatch repair-deficient metastatic colorectal cancer (KEYNOTE-177): final analysis of a randomised, open-label, phase 3 study. Lancet Oncol. 23, 659–670 (2022).

    Article 
    CAS 
    PubMed 

    Google Scholar
     

  • Sinicrope, F. A. et al. Randomized trial of standard chemotherapy alone or combined with atezolizumab as adjuvant therapy for patients with stage III colon cancer and deficient mismatch repair (ATOMIC, Alliance A021502) [abstract]. J. Clin. Oncol. 37 (Suppl. 15), e15169 (2019).

    Article 

    Google Scholar
     

  • André, T., Cohen, R. & Salem, M. E. Immune checkpoint blockade therapy in patients with colorectal cancer harboring microsatellite instability/mismatch repair deficiency in 2022. Am. Soc. Clin. Oncol. Educ. Book 42, 233–241 (2022).

    Article 

    Google Scholar
     

  • Sargent, D. J. et al. Defective mismatch repair as a predictive marker for lack of efficacy of fluorouracil-based adjuvant therapy in colon cancer. J. Clin. Oncol. 28, 3219–3226 (2010).

    Article 
    CAS 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • de Rosa, N. et al. DNA mismatch repair deficiency in rectal cancer: benchmarking its impact on prognosis, neoadjuvant response prediction, and clinical cancer genetics. J. Clin. Oncol. 34, 3039–3046 (2016).

    Article 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Cercek, A. et al. PD-1 blockade in mismatch repair-deficient, locally advanced rectal cancer. N. Engl. J. Med. 386, 2363–2376 (2022).

    Article 
    CAS 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Heneghan, H. M., Martin, S. T. & Winter, D. C. Segmental vs extended colectomy in the management of hereditary nonpolyposis colorectal cancer: a systematic review and meta-analysis. Colorectal Dis. 17, 382–389 (2015).

    Article 
    CAS 
    PubMed 

    Google Scholar
     

  • Anele, C. C. et al. Risk of metachronous colorectal cancer following colectomy in Lynch syndrome: a systematic review and meta-analysis. Colorectal Dis. 19, 528–536 (2017).

    Article 
    CAS 
    PubMed 

    Google Scholar
     

  • You, Y. N. et al. Segmental vs. extended colectomy: measurable differences in morbidity, function, and quality of life. Dis. Colon Rectum 51, 1036–1043 (2008).

    Article 
    PubMed 

    Google Scholar
     

  • Etchegary, H., Dicks, E., Watkins, K., Alani, S. & Dawson, L. Decisions about prophylactic gynecologic surgery: a qualitative study of the experience of female Lynch syndrome mutation carriers. Hereditary Cancer Clin. Pract. 13, 10 (2015).

    Article 

    Google Scholar
     

  • Velikova, G., Stark, D. & Selby, P. Quality of life instruments in oncology. Eur. J. Cancer 35, 1571–1580 (1999).

    Article 
    CAS 
    PubMed 

    Google Scholar
     

  • Ahnen, D. J. et al. The increasing incidence of young-onset colorectal cancer: a call to action. Mayo Clin. Proc. 89, 216–224 (2014).

    Article 
    PubMed 

    Google Scholar
     

  • Kneuertz, P. J. et al. Overtreatment of young adults with colon cancer: more intense treatments with unmatched survival gains. JAMA Surg. 150, 402–409 (2015).

    Article 
    PubMed 

    Google Scholar
     

  • You, Y. N. et al. Young-onset rectal cancer: presentation, pattern of care and long-term oncologic outcomes compared to a matched older-onset cohort. Ann. Surg. Oncol. 18, 2469–2476 (2011).

    Article 
    PubMed 

    Google Scholar
     

  • Soliman, H. & Agresta, S. V. Current issues in adolescent and young adult cancer survivorship. Cancer Control. 15, 55–62 (2008).

    Article 
    PubMed 

    Google Scholar
     

  • Perl, G. et al. Young patients and gastrointestinal (GI) tract malignancies – are we addressing the unmet needs. BMC Cancer 16, 630 (2016).

    Article 
    CAS 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Avis, N. E., Crawford, S. & Manuel, J. Quality of life among younger women with breast cancer. J. Clin. Oncol. 23, 3322–3330 (2005).

    Article 
    PubMed 

    Google Scholar
     

  • Werner-Lin, A. et al. Waiting and “weighted down”: the challenge of anticipatory loss for individuals and families with Li-Fraumeni syndrome. Fam. Cancer 19, 259–268 (2020).

    Article 
    PubMed 

    Google Scholar
     

  • Stupart, D., Win, A. K., Winship, I. M. & Jenkins, M. Fertility after young-onset colorectal cancer: a study of subjects with Lynch syndrome. Colorectal Dis. 17, 787–793 (2015).

    Article 
    CAS 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Burton-Chase, A. M. et al. Health-related quality of life in colorectal cancer survivors: are there differences between sporadic and hereditary patients. J. Patient Rep. Outcomes 2, 21 (2017).

    Article 
    PubMed 

    Google Scholar
     

  • Sun, R. et al. The incidence and risk factors of low anterior resection syndrome (LARS) after sphincter-preserving surgery of rectal cancer: a systematic review and meta-analysis. Support. Care Cancer 29, 7249–7258 (2021).

    Article 
    PubMed 

    Google Scholar
     

  • Al Rashid, F. et al. The impact of bowel dysfunction on health-related quality of life after rectal cancer surgery: a systematic review. Tech. Coloproctol. https://doi.org/10.1007/s10151-022-02594-0 (2022).

    Article 
    PubMed 

    Google Scholar
     

  • Bailey, C. E. et al. Functional deficits and symptoms of long-term survivors of colorectal cancer treated by multimodality therapy differ by age at diagnosis. J. Gastrointest. Surg. 19, 180–188 (2015).

    Article 
    PubMed 

    Google Scholar
     

  • Rashedi, A. S. et al. Survey of third-party parenting options associated with fertility preservation available to patients with cancer around the globe. JCO Glob. Oncol. https://doi.org/10.1200/JGO.2017.009944 (2020).

    Article 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Corrigan, K. L. et al. Financial toxicity impact on younger versus older adults with cancer in the setting of care delivery. Cancer https://doi.org/10.1002/cncr.34220 (2022).

    Article 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Morton, S. M. et al. Cohort profile: growing up in New Zealand. Int. J. Epidemiol. 42, 65–75 (2013).

    Article 
    PubMed 

    Google Scholar
     

  • Connelly, R. & Platt, L. Cohort profile: UK Millennium Cohort Study (MCS). Int. J. Epidemiol. 43, 1719–1725 (2014).

    Article 
    PubMed 

    Google Scholar
     

  • Kooijman, M. N. et al. The Generation R Study: design and cohort update 2017. Eur. J. Epidemiol. 31, 1243–1264 (2016).

    Article 
    PubMed 

    Google Scholar
     

  • Cirillo, P. M. & Cohn, B. A. Pregnancy complications and cardiovascular disease death: 50-year follow-up of the Child Health and Development Studies pregnancy cohort. Circulation 132, 1234–1242 (2015).

    Article 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Fuchs, C. S. et al. A prospective study of family history and the risk of colorectal cancer. N. Engl. J. Med. 331, 1669–1674 (1994).

    Article 
    CAS 
    PubMed 

    Google Scholar
     

  • Clavel-Chapelon, F. et al. E3N, a French cohort study on cancer risk factors. Eur. J. Cancer Prev. 6, 473–478 (1997).

    Article 
    CAS 
    PubMed 

    Google Scholar
     

  • Møller, P. et al. Cancer incidence and survival in Lynch syndrome patients receiving colonoscopic and gynaecological surveillance: first report from the prospective Lynch syndrome database. Gut 66, 464–472 (2017).

    Article 
    PubMed 

    Google Scholar
     

  • Lynch, H. et al. Milestones of Lynch syndrome: 1895–2015. Nat. Rev. Cancer 15, 181–194 (2015).

    Article 
    CAS 
    PubMed 

    Google Scholar
     



  • Source link

    Related Articles

    Leave a Reply

    Stay Connected

    9FansLike
    4FollowersFollow
    0SubscribersSubscribe
    - Advertisement -spot_img

    Latest Articles

    %d bloggers like this: